{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:58:35Z","timestamp":1768719515098,"version":"3.49.0"},"reference-count":108,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CI-IPOP","award":["CI-IPOFB-GEBC-2018"],"award-info":[{"award-number":["CI-IPOFB-GEBC-2018"]}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-29043"],"award-info":[{"award-number":["POCI-01-0145-FEDER-29043"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Epitranscriptomics has gained ground in recent years, especially after the advent of techniques for accurately studying these mechanisms. Among all modifications occurring in RNA molecules, N6-methyladenosine (m6A) is the most frequent, especially among mRNAs. m6A has been demonstrated to play important roles in many physiological processes and several disease states, including various cancer models (from solid to liquid tumors). Tumor cells\u2019 epitranscriptome is indeed disrupted in a way to promote cancer-prone features, by means of up\/downregulating m6A-related players: the so-called writers, readers and erasers. These proteins modulate m6A establishment, removal and determine mRNAs fate, acting in a context-dependent manner, so that a single player may act as an oncogenic signal in one tumor model (methyltransferase like 3 (METTL3) in lung cancer) and as a tumor suppressor in another context (METTL3 in glioblastoma). Despite recent advances, however, little attention has been directed towards urological cancer. By means of a thorough analysis of the publicly available TCGA (The Cancer Genome Atlas) database, we disclosed the most relevant players in four major urogenital neoplasms\u2014kidney, bladder, prostate and testicular cancer\u2014for prognostic, subtype discrimination and survival purposes. In all tumor models assessed, the most promising player was shown to be Vir like m6A methyltransferase associated (VIRMA), which could constitute a potential target for personalized therapies.<\/jats:p>","DOI":"10.3390\/genes9110552","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T02:42:41Z","timestamp":1542163361000},"page":"552","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"first","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6807","authenticated-orcid":false,"given":"Daniela","family":"Barros-Silva","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[{"name":"Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tcb.2014.08.010","article-title":"Epigenetics reloaded: The single-cell revolution","volume":"24","author":"Bheda","year":"2014","journal-title":"Trends Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nchembio.482","article-title":"Grand challenge commentary: RNA epigenetics?","volume":"6","author":"He","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gpb.2017.03.002","article-title":"The RNA modification N(6)-methyladenosine and its implications in human disease","volume":"15","author":"Batista","year":"2017","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13059-018-1394-4","article-title":"A panoramic view of RNA modifications: Exploring new frontiers","volume":"19","author":"Zhang","year":"2018","journal-title":"Genome Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","article-title":"MODOMICS: A database of RNA modification pathways. 2017 update","volume":"46","author":"Boccaletto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cell.2018.06.046","article-title":"SnapShot: Messenger RNA modifications","volume":"174","author":"Davalos","year":"2018","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jgg.2013.10.002","article-title":"Methylation modifications in eukaryotic messenger RNA","volume":"41","author":"Liu","year":"2014","journal-title":"J. Genet. Genom."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Jacob, R., Zander, S., and Gutschner, T. (2017). The dark side of the epitranscriptome: Chemical modifications in long non-coding RNAs. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112387"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrg.2016.47","article-title":"RNA modifications: What have we learned and where are we headed?","volume":"17","author":"Frye","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gpb.2017.03.003","article-title":"Epitranscriptomics: Toward a better understanding of RNA modifications","volume":"15","author":"Xiong","year":"2017","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tibs.2012.12.006","article-title":"N6-methyl-adenosine modification in messenger and long non-coding RNA","volume":"38","author":"Pan","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nsmb.3162","article-title":"N6-methyladenosine-encoded epitranscriptomics","volume":"23","author":"Liu","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm3785","article-title":"The dynamic epitranscriptome: N6-methyladenosine and gene expression control","volume":"15","author":"Meyer","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/febs.13614","article-title":"N6-methyladenosine modification in mRNA: Machinery, function and implications for health and diseases","volume":"283","author":"Maity","year":"2016","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nmeth.4110","article-title":"Epitranscriptome sequencing technologies: Decoding RNA modifications","volume":"14","author":"Li","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12930","DOI":"10.1039\/C7CC07699A","article-title":"Detection of N(6)-methyladenosine based on the methyl-sensitivity of MazF RNA endonuclease","volume":"53","author":"Imanishi","year":"2017","journal-title":"Chem. Commun. (Camb.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1098\/rsob.170077","article-title":"Understanding RNA modifications: The promises and technological bottlenecks of the \u2018epitranscriptome\u2019","volume":"7","author":"Schaefer","year":"2017","journal-title":"Open Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","article-title":"Reading m(6)A in the transcriptome: M(6)A-binding proteins","volume":"28","author":"Patil","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Visvanathan, A., and Somasundaram, K. (2018). mRNA traffic control reviewed: N6-methyladenosine (m(6)A) takes the driver\u2019s seat. Bioessays, 40.","DOI":"10.1002\/bies.201700093"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m(6)A readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sbi.2017.05.011","article-title":"Readers, writers and erasers of N(6)-methylated adenosine modification","volume":"47","author":"Wu","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gpb.2018.03.001","article-title":"Structural Insights into N(6)-methyladenosine (m(6)A) modification in the transcriptome","volume":"16","author":"Huang","year":"2018","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/nar\/gky130","article-title":"N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential","volume":"46","author":"Yang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature25784","article-title":"The SMAD2\/3 interactome reveals that TGFbeta controls m(6)A mRNA methylation in pluripotency","volume":"555","author":"Bertero","year":"2018","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuron.2017.12.036","article-title":"Epitranscriptomic m(6)A regulation of axon regeneration in the adult mammalian nervous system","volume":"97","author":"Weng","year":"2018","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"m(6)A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1261417","article-title":"Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation","volume":"347","author":"Geula","year":"2015","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e12428","DOI":"10.1111\/gbb.12428","article-title":"The emerging role of mRNA methylation in normal and pathological behavior","volume":"17","author":"Engel","year":"2017","journal-title":"Genes Brain Behav."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1002\/jcp.26507","article-title":"Increased N6-Methyladenosine causes infertility is associated with FTO expression","volume":"233","author":"Ding","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb2902","article-title":"N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells","volume":"16","author":"Wang","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/nmicrobiol.2016.11","article-title":"Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells","volume":"1","author":"Lichinchi","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-methylation-dependent RNA processing controls the speed of the circadian clock","volume":"155","author":"Fustin","year":"2013","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","article-title":"Integrated molecular characterization of testicular germ cell tumors","volume":"23","author":"Shen","year":"2018","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5306\/wjco.v9.i3.42","article-title":"Epitranscriptomics of cancer","volume":"9","author":"Tusup","year":"2018","journal-title":"World J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-018-0847-4","article-title":"Novel insights on m(6)A RNA methylation in tumorigenesis: A double-edged sword","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","article-title":"m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells","volume":"15","author":"Batista","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/2159-8290.CD-16-1292","article-title":"The epitranscriptome of noncoding RNAs in cancer","volume":"7","author":"Esteller","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fbioe.2018.00089","article-title":"Link between m6A modification and cancers","volume":"6","author":"Liu","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2017.08.030","article-title":"Roles of RNA methylation by means of N(6)-methyladenosine (m(6)A) in human cancers","volume":"408","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1111\/jcmm.13804","article-title":"The dual role of N6-methyladenosine modification of RNAs is involved in human cancers","volume":"22","author":"He","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trecan.2018.01.006","article-title":"Deciphering the epitranscriptome in cancer","volume":"4","author":"Lian","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","article-title":"Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s13277-012-0372-9","article-title":"Association between FTO gene polymorphism and cancer risk: Evidence from 16,277 cases and 31,153 controls","volume":"33","author":"Li","year":"2012","journal-title":"Tumour Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2014.06.006","article-title":"Role of RNA methyltransferases in tissue renewal and pathology","volume":"31","author":"Blanco","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng.2571","article-title":"A variant in FTO shows association with melanoma risk not due to BMI","volume":"45","author":"Iles","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng.2561","article-title":"Genome-wide association studies identify four ER negative-specific breast cancer risk loci","volume":"45","author":"Couch","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_50","first-page":"13405","article-title":"Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications","volume":"8","author":"Tan","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Singh, B., Kinne, H.E., Milligan, R.D., Washburn, L.J., Olsen, M., and Lucci, A. (2016). Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159072"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64527","DOI":"10.18632\/oncotarget.11743","article-title":"Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_53","first-page":"E2047","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","article-title":"HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g","volume":"415","author":"Cai","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase METTL3 promotes liver cancer progression through YTHDF2 dependent post-transcriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/CBM-170791","article-title":"Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"21","author":"Zhao","year":"2018","journal-title":"Cancer Biomark."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6)-methyladenosine-dependent primary microRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"ref_58","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1080\/15384101.2017.1380125","article-title":"YTH domain family 2 orchestrates epithelial-mesenchymal transition\/proliferation dichotomy in pancreatic cancer cells","volume":"16","author":"Chen","year":"2017","journal-title":"Cell Cycle"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00535-013-0748-7","article-title":"WTAP regulates migration and invasion of cholangiocarcinoma cells","volume":"48","author":"Jo","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.18632\/oncotarget.23554","article-title":"Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer","volume":"9","author":"Nishizawa","year":"2018","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2016.02.022","article-title":"RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated","volume":"376","author":"Tanabe","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2018.01.049","article-title":"Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications","volume":"419","author":"Porcellini","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3892\/or.2017.5904","article-title":"FTO expression is associated with the occurrence of gastric cancer and prognosis","volume":"38","author":"Xu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"98918","DOI":"10.18632\/oncotarget.22041","article-title":"Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mc.22782","article-title":"FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting \u03b2-catenin through mRNA demethylation","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"m(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","article-title":"MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA","volume":"482","author":"Du","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-017-0410-6","article-title":"Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia","volume":"10","author":"Kwok","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/leu.2014.16","article-title":"WTAP is a novel oncogenic protein in acute myeloid leukemia","volume":"28","author":"Bansal","year":"2014","journal-title":"Leukemia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/90054","article-title":"Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia","volume":"28","author":"Ma","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.transproceed.2010.07.034","article-title":"Wilms\u2019 tumor 1 as a novel target for immunotherapy of leukemia","volume":"42","author":"Schmitt","year":"2010","journal-title":"Transplant. Proc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","article-title":"Oncogenic isocitrate dehydrogenase mutations: Mechanisms, models, and clinical opportunities","volume":"3","author":"Cairns","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccell.2017.04.001","article-title":"IDH Mutation, competitive inhibition of FTO, and RNA methylation","volume":"31","author":"Elkashef","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrurol.2012.225","article-title":"Risk stratification in prostate cancer screening","volume":"10","author":"Roobol","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1101\/gad.1965810","article-title":"Molecular genetics of prostate cancer: New prospects for old challenges","volume":"24","author":"Shen","year":"2010","journal-title":"Genes Dev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.euf.2016.11.012","article-title":"The molecular evolution of castration-resistant prostate cancer","volume":"2","author":"Ceder","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2217\/bmm.12.72","article-title":"Biomarkers for the diagnosis of new and recurrent prostate cancer","volume":"6","author":"Sardana","year":"2012","journal-title":"Biomark. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2012.02.011","article-title":"Epigenetic biomarkers in prostate cancer: Current and future uses","volume":"342","author":"Chiam","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.18632\/oncotarget.23365","article-title":"Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: Renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/andr.293","article-title":"International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973\u20132007","volume":"3","author":"Trabert","year":"2015","journal-title":"Andrology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/annonc\/mds579","article-title":"Maintaining success, reducing treatment burden, focusing on survivorship: Highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer","volume":"24","author":"Beyer","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/epi-2016-0081","article-title":"The epigenetics of testicular germ cell tumors: Looking for novel disease biomarkers","volume":"9","author":"Costa","year":"2017","journal-title":"Epigenomics"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lobo, J., Costa, A.L., Vilela-Salgueiro, B., Rodrigues, A., Guimaraes, R., Cantante, M., Lopes, P., Antunes, L., Jeronimo, C., and Henrique, R. (2018). Testicular germ cell tumors: Revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists. Hum. Pathol.","DOI":"10.1016\/j.humpath.2018.07.016"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.eururo.2016.08.013","article-title":"Testicular germ cell tumors go epigenetics: Will miR-371a-3p replace classical serum biomarkers?","volume":"71","author":"Henrique","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11523-016-0439-4","article-title":"Will testicular germ cell tumors remain untargetable?","volume":"11","author":"Aoun","year":"2016","journal-title":"Target Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"104654","DOI":"10.18632\/oncotarget.20992","article-title":"Testicular cancer from diagnosis to epigenetic factors","volume":"8","author":"Boccellino","year":"2017","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrurol.2016.170","article-title":"The present and future of serum diagnostic tests for testicular germ cell tumours","volume":"13","author":"Murray","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1387\/ijdb.130017ll","article-title":"Role of epigenetics in the etiology of germ cell cancer","volume":"57","author":"Stoop","year":"2013","journal-title":"Int. J. Dev. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group","volume":"15","author":"Wilkinson","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"96103","DOI":"10.18632\/oncotarget.21726","article-title":"The M6A methyltransferase METTL3: Acting as a tumor suppressor in renal cell carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/9\/11\/552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:31Z","timestamp":1760196571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/9\/11\/552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":108,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["genes9110552"],"URL":"https:\/\/doi.org\/10.3390\/genes9110552","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]}}}